Library

X
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Brain microdialysis  (1)
  • Dopamine release  (1)
  • 1
    Electronic Resource
    Electronic Resource
    Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain microdialysis (1990)
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 342 (1990), S. 528-534 
    Details
    ISSN: 1432-1912
    Keywords: Brain microdialysis ; Acetylcholine ; Dopamine ; Calcium ; Perfusion solution
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Brain microdialysis experiments were performed to assess the effects of calcium (1.2 mmol/l and 3.4 mmol/l) in the perfusio solution on a variety of pharmacological treatments known to affect the release of dopamine (DA) and/or acetylcholine (ACh). Intrastriatal infusion of the muscarinic receptor agonist oxotremorine (100 μM), the selective dopamine D-2 receptor agonist (−)-N-0437 (1 μM), and the indirect DA agonists (+)amphetamine (10 μM) and nomifensine (1 μM) via the dialysis probe did not affect the overflow of ACh when the perfusion fluid contained 3.4 mmol/l calcium. In contrast, these compounds produced pronounced decreases in the overflow of ACh at 1.2 mmol/l calcium. Intrastriatal infusion of the muscarinic receptor antagonist atropine (1 μM) increased the output of ACh both at 1.2 mmol/l and 3.4 mmol/1 calcium. The selective DA D-2 receptor antagonist (−)-sulpiride (1 μM) did not affect the overflow of ACh at either calcium concentration. Infusion of oxotremorine and atropine had no effect on the overflow of DA at either 1.2 mmol/l or 3.4 mmol/l calcium. (−)-N-0437 decreased and (−)-sulpirde increased DA overflow, both effects being independent of the calcium concentration in the perfusion fluid. Nomifensine and (−)amphetamine caused relatively (but not absolutely) larger increases in the overflow of DA at 1.2 mmol/1 calcium. These findings emphasize the critical importance of the calcium concentration of the perfusion fluid in determining the nature of pharmacological responses in microdialysis experiments, and demonstrate that locally applied dopaminergic drugs can modulate striatal cholinergic function.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/BF00169041
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 2
    Electronic Resource
    Electronic Resource
    The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis (1992)
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 345 (1992), S. 144-152 
    Details
    ISSN: 1432-1912
    Keywords: Acetylcholine release ; Dopamine release ; Microdialysis ; Striatum ; D-1 and D-2 dopamine receptors ; Post-implantation interval
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The effect of intrastriatal application of D-1, D-2 and indirect dopaminergic drugs on the release of striatal acetylcholine as a function of the post-implantation intervals was studied using in vivo microdialysis. The dopamine, D-2 agonists LY 171555 and (−)N0437 inhibited the release of striatal acetylcholine to 40% of control values 16–24 h after implantation of the dialysis cannula. When LY 171555 was infused 40–48 h after implantation of the dialysis cannula, the response was attenuated to 20% of control values. Meanwhile, the effectiveness of infusions of the antagonists (−)sulpiride and haloperidol was augmented from a non significant effect at 16–24 h to a 150% increase 40–48 h after implantation of the cannula. Infusions of the dopamine releasing agent amphetamine or the dopamine uptake inhibitor nomifensine resulted in a dose-dependent increase in the overflow of dopamine. Not until a sevenfold increase in the level of dopamine was seen, the release of acetylcholine was significantly affected. This hyporesponsiveness of the striatal cholinergic interneurons to endogenous dopamine could not be attributed to dopamine D-1 receptor activation, since no effects on striatal acetylcholine release were found by intrastriatal infusions of the selective D-1 agonist CY 208-243 or the selective D-1 antagonist SCH 23390. The results indicate that dopamine D-2 receptors are involved in the regulation of striatal acetylcholine release and that these receptors are tonically occupied by endogenous dopamine under the present experimental conditions 40–48 h after probe implantation. The fact that cholinergic responses to intrastriatally applied dopaminergic agents are dynamic with respect to the time between implantation surgery of the dialysis tube and the experimental measurements suggests that the striatal neuronal system is perturbated by the implantation of a dialysis probe for a considerable length of time.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/BF00165729
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...